Hello, Welcome to Shine Consultant !
Summit & Event Shine Speaker Bureau Shine Advisor Shine Event Service
  • Summit & Event :
    With field research of markets and industries which is analyzed from a global strategic perspective by our professional teams, as well as hot topics which interest leadership and management, Shine Consultant provides you with one-stop platform of dialogue, practice -sharing and social network!
  • Shine Speaker Bureau:
    Committed to provide keynote speakers, executive learning masterclasses and boardroom advisory for global enterprises and institutions, each service provides a deeper and more interactive experience, especially for small, selected audiences and key individuals. We have the resources of the most influential business leaders and experts, who are the most outstanding representatives in their fields. Our team consists of experienced speech and event managers, and we focus on building long-term and in-depth partnerships.
  • Shine Advisor:
    As world-class insight network, we connects clients-decision makers with vetted subject matter experts-advisors. Our clients leverage the insights and perspectives shared by our advisors to stay informed and make better business decisions.We have over 600,000 Shine Advisors in 20 industries, which continues to grow every day.
  • Shine Event Service:
    Committed to be the world's most professional provider of industrial Summit & Event. We provide one-stop professional services, including investigating and planning, on-demand inviting, marketing and promoting, operating, project management, live& digital conference, each service is performed by an experienced professional team matched with long-term industrial resources. We focus on establishing long-term and in-depth partnerships.
Guest Information
Yanshan Huang
Yanshan Huang
Positions:

General Manager

 

 

Company:

 DOER Biologics

 Huang got M.D at Zhejiang Universtiy and has more than 20 years experiences on biopharmaceuticals. He had been as CSO in Hangzhou Jiuyuan Gene Engineering co., LTD, during which he was responsible for getting two biosimilar market licenses (include the first G-CSF in China) and a clinic trial permission license for an innovative recombinant protein drug. Since 2008, Dr. Huang was a co-founder of T-mab Biopharma and responsible for the development of T-mab’s therapeutic antibody and protein projects. In T-Mab, he had set up two technology platforms -- the long-acting recombinant protein drugs and therapeutic monoclonal antibodies, and developed 3 innovative biological drugs and 1 biosimilars with 30M RMB shareholder investment, and all are in clinical trials in China. In 2015, T-Mab was acquired by a domestic big pharma in near 300M RMB. After that, Dr. Huang found Doer Biologics in Hangzhou in 2015, which focus in developing biobetterand "best-in-class" biodrugs with creative long-acting biodrug platform and innovative multi-domain technology.